ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹269 Cr | ₹52 Cr | ₹107 Cr | ₹-86 Cr | ₹73 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ABBOTT INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹-86 Cr |
| Mar2021 | ₹73 Cr |
How is Net Cash Inflow / Outflow of ABBOTT INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | 416.32 | |
| Mar2024 | ₹52 Cr | -51.32 | |
| Mar2023 | ₹107 Cr | Positive | |
| Mar2022 | ₹-86 Cr | Negative | |
| Mar2021 | ₹73 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹53,998.3 Cr | -3.8% | -3.5% | -10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -3.8% |
-3.5% |
-10.3% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses